Study Stopped
Temporary protocol lapse
Ovarian Tissue Cryopreservation for Fertility Preservation in Girls and Women
1 other identifier
interventional
24
1 country
1
Brief Summary
This study will compare efficacy of ovarian tissue freezing using slow-freeze versus vitrification methods.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Aug 2017
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 11, 2017
CompletedFirst Submitted
Initial submission to the registry
October 20, 2017
CompletedFirst Posted
Study publicly available on registry
June 28, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 10, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
October 10, 2027
ExpectedJune 18, 2023
June 1, 2023
8.2 years
October 20, 2017
June 14, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Effect of vitrification and slow freeze cryopreservation methods on follicular survival
Investigators will explore and compare the impact of vitrification and slow freeze cryopreservation methods by evaluating follicular survival using classic histological analysis of follicular morphology.
5+ years
Secondary Outcomes (1)
Live birth rates in patients using cryopreserved ovarian tissue
5+ years
Study Arms (1)
Collection
OTHERThere is only one arm of the study, all patients enrolled will have surgery in which the attempt will be made to collect ovarian tissue.
Interventions
Patients undergoing surgery for any indicated procedure for fertility-threatening treatment will have attempt at collecting ovarian tissue at time of surgery.
Eligibility Criteria
You may qualify if:
- Female Patients only
- years of age.
- Will undergo surgery, chemotherapy, drug treatment and/or radiation for the treatment or prevention of a medical condition or malignancy that places the patient at risk for impaired ovarian function and infertility OR, have a medical condition or malignancy that requires removal of all or part of one or both ovaries.
- May have newly diagnosed or recurrent disease. Those not enrolled at the time of initial diagnosis are eligible if they have not received therapy that is viewed as likely to result in complete and permanent loss of ovarian function.
- Signed an approved informed consent and authorization permitting the release of personal health information. The patient and/or the patient's legally authorized guardian(s) must acknowledge in writing that consent for specimen collection has been obtained, in accordance with institutional policies approved by the U.S. Department of Health and Human Services.
You may not qualify if:
- Girls and women with psychological, psychiatric, or other conditions which prevent giving informed consent.
- Girls and women whose underlying medical condition significantly increases their risk of complications from anesthesia and surgery.
- Girls and women who are permanently menopausal, as documented by history and FSH levels.
- Girls and women who are pregnant.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Texas Children's Hospital Pavilion For Women
Houston, Texas, 77030, United States
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Terri L Woodard, MD
Baylor College of Medicine
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
October 20, 2017
First Posted
June 28, 2022
Study Start
August 11, 2017
Primary Completion
October 10, 2025
Study Completion (Estimated)
October 10, 2027
Last Updated
June 18, 2023
Record last verified: 2023-06